1. Home
  2. MAIA vs ITRG Comparison

MAIA vs ITRG Comparison

Compare MAIA & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • ITRG
  • Stock Information
  • Founded
  • MAIA 2018
  • ITRG 1997
  • Country
  • MAIA United States
  • ITRG Canada
  • Employees
  • MAIA N/A
  • ITRG N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • ITRG Precious Metals
  • Sector
  • MAIA Health Care
  • ITRG Basic Materials
  • Exchange
  • MAIA Nasdaq
  • ITRG Nasdaq
  • Market Cap
  • MAIA 62.4M
  • ITRG 84.2M
  • IPO Year
  • MAIA 2022
  • ITRG N/A
  • Fundamental
  • Price
  • MAIA $2.82
  • ITRG $1.20
  • Analyst Decision
  • MAIA
  • ITRG Strong Buy
  • Analyst Count
  • MAIA 0
  • ITRG 1
  • Target Price
  • MAIA N/A
  • ITRG $3.75
  • AVG Volume (30 Days)
  • MAIA 60.0K
  • ITRG 259.4K
  • Earning Date
  • MAIA 11-05-2024
  • ITRG 11-12-2024
  • Dividend Yield
  • MAIA N/A
  • ITRG N/A
  • EPS Growth
  • MAIA N/A
  • ITRG N/A
  • EPS
  • MAIA N/A
  • ITRG N/A
  • Revenue
  • MAIA N/A
  • ITRG N/A
  • Revenue This Year
  • MAIA N/A
  • ITRG N/A
  • Revenue Next Year
  • MAIA N/A
  • ITRG $360.53
  • P/E Ratio
  • MAIA N/A
  • ITRG N/A
  • Revenue Growth
  • MAIA N/A
  • ITRG N/A
  • 52 Week Low
  • MAIA $0.82
  • ITRG $0.64
  • 52 Week High
  • MAIA $5.99
  • ITRG $1.28
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 50.98
  • ITRG 66.49
  • Support Level
  • MAIA $2.36
  • ITRG $0.95
  • Resistance Level
  • MAIA $2.72
  • ITRG $1.28
  • Average True Range (ATR)
  • MAIA 0.22
  • ITRG 0.07
  • MACD
  • MAIA 0.02
  • ITRG 0.01
  • Stochastic Oscillator
  • MAIA 72.28
  • ITRG 77.27

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

Share on Social Networks: